FDA Litigates To Wash Off Sanitizer Ebola Claim, Warns On Colloidal Silver Benefits
This article was originally published in The Rose Sheet
Executive Summary
A complaint filed in federal court in California seeks an order to block Innovative BioDefense from distributing Zylast antiseptic hand sanitizer products that, due to its claims, are unapproved new drugs under FDA regulations. A warning letter to Silver Armor states that drug claims render its Silver Ramon and Natural Health brand products, which contain colloidal silver, unapproved new drugs and that the is noncompliant with supplement GMP regulations.